Medline Inc. Class A Common Stock Cash Flow Conversion Efficiency
Medline Inc. Class A Common Stock cash flow conversion efficiency. Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.037x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($715.00 Million) by net assets ($19.08 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medline Inc. Class A Common Stock (2023–2025)
Cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View MDLN live share price for real-time trading data and today's change.
Medline Inc. Class A Common Stock Cash Flow Conversion Ratio Explained
Medline Inc. Class A Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency. Also see MDLN market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Copart Inc
NASDAQ:CPRT
|
0.013x |
|
Everpure, Inc.
NYSE:P
|
0.125x |
|
Cheniere Energy Partners LP
NYSE:CQP
|
11.667x |
|
Otis Worldwide Corp
NYSE:OTIS
|
-0.071x |
|
Iron Mountain Incorporated
NYSE:IRM
|
-0.440x |
|
Shinhan Financial Group Co Ltd
NYSE:SHG
|
0.219x |
|
Roblox Corp
NYSE:RBLX
|
1.400x |
|
Bajaj Finserv Limited
NSE:BAJAJFINSV
|
-0.180x |
Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. Review MDLN free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.29 Billion | $1.74 Billion | 0.090x | -15.53% |
| 2024-12-31 | $16.52 Billion | $1.77 Billion | 0.107x | +7.86% |
| 2023-12-31 | $16.98 Billion | $1.69 Billion | 0.099x | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more